Oryzon Secures Vafidemstat Patent Allowances in Four Countries
Bitget2026/10/15 06:05- Oryzon Genomics received decisions to grant vafidemstat patents in four markets, expanding protection for psychiatric and neurodevelopmental uses.
- South Korean and Philippine allowances cover non-aggressive borderline personality disorder symptoms, with protection expected through at least 2040, excluding potential extensions.
- New Zealand's allowance covers aggression and social withdrawal, with protection expected through at least 2038, excluding potential extensions or adjustments.
- Mexico's allowance covers certain non-aggressive autism spectrum disorder symptoms; once granted, protection runs through at least 2040, excluding potential extensions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic spends $3.4 billion to purchase gas-fired power equipment to supply electricity for data centers
In September, Anthropic directly acquired Caterpillar equipment orders worth 3.4 billion USD, securing 1.7 GW of gas generator units, marking the largest single purchase of power generation equipment in AI history. This move bypassed utility middlemen, capturing scarce capacity at prices set years ago with near-term delivery. It is part of Anthropic's plan to invest over 895 billion USD in computing infrastructure by 2045.
Why Nintendo Stock Is One to Watch Ahead of the Holiday Season
A wallet address sold 1.44 million TRX via SunSwap in exchange for 460,000 USDT.
Data: Whales have cumulatively withdrawn approximately 13.4 million USDT from a certain exchange.
Crypto prices
More
